Compound Neelubar cold-treating granules and production method thereof

A production method and granule technology, which can be applied in pharmaceutical formulations, plant raw materials, respiratory diseases, etc., can solve the problems of western medicine side effects, clinical curative effect, inconvenient carrying, etc., to prolong the incubation time, improve antiviral effect, and solve the clinical curative effect high impact effect

Active Publication Date: 2016-10-26
XINJIANG JINSHIKANG PHARMA
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The present invention provides a compound Nirupa Ganmao granule and a production method thereof, which overcomes the deficiencies of the above-mentioned prior art, and can effectively solve the side effects of western medicine and the traditional decoction of traditional Chinese medicine that have a great influence on clinical curative effect and are not easy to carry when taking a large dose. Convenience question

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound Neelubar cold-treating granules and production method thereof
  • Compound Neelubar cold-treating granules and production method thereof
  • Compound Neelubar cold-treating granules and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1, the compound Nirupa Ganmao Granules, the raw materials include 5 to 15 parts of Artemisia argyi, 3 to 9 parts of Herbs, 5 to 15 parts of Dried Ginger, 3 to 9 parts of Nasturtium in parts by weight, 5 to 15 parts of Ragbuk, 3 to 9 parts of Jujube, and 3 to 9 parts of Licorice.

Embodiment 2

[0023] Example 2, the compound Nirupa Ganmao Granules, the raw materials include 5 or 15 parts of Artemisia argyi, 3 or 9 parts of Herbs, 5 or 15 parts of Dried Ginger, 3 or 9 parts of Nasturtium in parts by weight, 5 or 15 parts of Ragbuk fruit, 3 or 9 parts of jujube, 3 or 9 parts of licorice.

Embodiment 3

[0024]Embodiment 3, optimize as above-mentioned embodiment, the production method of this compound Nirupa Ganmao granule, carry out according to the following steps: the first step, add the required amount of Artemisia argyi, Trolla nasturtium and dried ginger with a weight equal to Artemisia argyi, 6 times to 10 times the volume percentage of the total weight of nasturtium and dried ginger is 50% to 80% ethanol aqueous solution reflux extraction 2 to 4 times, and the time of each alcohol extraction is 1.0 hour to 3.0 hours, each reflux The temperature of the extraction is 80°C to 100°C, the alcohol extracts obtained each time are combined to obtain a mixture of alcohol extraction, and the mixture of alcohol extraction is concentrated under reduced pressure to obtain a compound with a relative density of 1.22 to 1.25 at a temperature of 60°C. The first clearing cream; the second step, crush the ragbuk fruit into the coarsest powder, add the required amount of the coarsest powde...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of Chinese herbal cold-treating medicines and relates to compound Neelubar cold-treating granules and a production method thereof. The raw materials contain, by weight, 5-15 parts of Artemisia rupestris L, 3-9 parts of Hyssopus officinalis, 5-15 parts of dried ginger, 3-9 parts of trollius chinensis bunge, 5-15 parts of Po bu mu go, 3-9 parts of jujube and 3-9 parts of licorice. The invention discloses compound Neelubar cold-treating granules for treating cold. The medicine has a good antiviral effect. In addition, the compound Neelubar cold-treating granules have a good effect of inhibiting influenza virus M2 protein and mRNA level in MDCK cells. Therefore, the medicine has little toxic and side effect relative to western medicines. Meanwhile, the problem that a traditional Chinese herbal decoction has a great impact on clinical efficacy and is inconvenient to carry when medication dosage is high is effectively solved.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines for treating colds, and relates to a compound Nirupa Ganmao granule and a production method thereof. Background technique [0002] Flu is a kind of common respiratory infectious disease, and is divided into common cold and influenza, and majority is caused by viral infection. In winter, colds have become a doom that people can't escape. Waves of flu hit, and some people even couldn't escape it again and again, suffering from repeated colds. Influenza is the source of all diseases, and influenza is the most serious infectious disease that broke out in the 20th century, and international pandemics have just occurred 3 times. From 1918 to 1920, the influenza that swept the world caused more than 20 million deaths, far higher than the number of people who died in the war in the First World War, and its harm was no less than that of war. At least 600 million people suffer from i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/16A61P11/00A61P11/14A61P29/00A61P11/06A61P31/16
CPCA61K9/1605A61K36/28A61K36/30A61K36/484A61K36/53A61K36/71A61K36/725A61K36/9068A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 王豪鹏
Owner XINJIANG JINSHIKANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap